Maryam Darvishian1, Maarten J Bijlsma2, Eelko Hak1, Edwin R van den Heuvel3. 1. Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; Unit of PharmacoEpidemiology and PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, Netherlands. 2. Unit of PharmacoEpidemiology and PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, Netherlands. 3. Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; Department of Mathematics and Computer Science, Eindhoven University of Technology, Eindhoven, Netherlands. Electronic address: e.r.v.d.heuvel@tue.nl.
Abstract
BACKGROUND: The application of test-negative design case-control studies to assess the effectiveness of influenza vaccine has increased substantially in the past few years. The validity of these studies is predicated on the assumption that confounding bias by risk factors is limited by design. We aimed to assess the effectiveness of influenza vaccine in a high-risk group of elderly people. METHODS: We searched the Cochrane library, Medline, and Embase up to July 13, 2014, for test-negative design case-control studies that assessed the effectiveness of seasonal influenza vaccine against laboratory confirmed influenza in community-dwelling people aged 60 years or older. We used generalised linear mixed models, adapted for test-negative design case-control studies, to estimate vaccine effectiveness according to vaccine match and epidemic conditions. FINDINGS: 35 test-negative design case-control studies with 53 datasets met inclusion criteria. Seasonal influenza vaccine was not significantly effective during local virus activity, irrespective of vaccine match or mismatch to the circulating viruses. Vaccination was significantly effective against laboratory confirmed influenza during sporadic activity (odds ratio [OR] 0·69, 95% CI 0·48-0·99) only when the vaccine matched. Additionally, vaccination was significantly effective during regional (match: OR 0·42, 95% CI 0·30-0·60; mismatch: OR 0·57, 95% CI 0·41-0·79) and widespread (match: 0·54, 0·46-0·62; mismatch: OR 0·72, 95% CI 0·60-0·85) outbreaks. INTERPRETATION: Our findings show that in elderly people, irrespective of vaccine match, seasonal influenza vaccination is effective against laboratory confirmed influenza during epidemic seasons. Efforts should be renewed worldwide to further increase uptake of the influenza vaccine in the elderly population. FUNDING: None.
BACKGROUND: The application of test-negative design case-control studies to assess the effectiveness of influenza vaccine has increased substantially in the past few years. The validity of these studies is predicated on the assumption that confounding bias by risk factors is limited by design. We aimed to assess the effectiveness of influenza vaccine in a high-risk group of elderly people. METHODS: We searched the Cochrane library, Medline, and Embase up to July 13, 2014, for test-negative design case-control studies that assessed the effectiveness of seasonal influenza vaccine against laboratory confirmed influenza in community-dwelling people aged 60 years or older. We used generalised linear mixed models, adapted for test-negative design case-control studies, to estimate vaccine effectiveness according to vaccine match and epidemic conditions. FINDINGS: 35 test-negative design case-control studies with 53 datasets met inclusion criteria. Seasonal influenza vaccine was not significantly effective during local virus activity, irrespective of vaccine match or mismatch to the circulating viruses. Vaccination was significantly effective against laboratory confirmed influenza during sporadic activity (odds ratio [OR] 0·69, 95% CI 0·48-0·99) only when the vaccine matched. Additionally, vaccination was significantly effective during regional (match: OR 0·42, 95% CI 0·30-0·60; mismatch: OR 0·57, 95% CI 0·41-0·79) and widespread (match: 0·54, 0·46-0·62; mismatch: OR 0·72, 95% CI 0·60-0·85) outbreaks. INTERPRETATION: Our findings show that in elderly people, irrespective of vaccine match, seasonal influenza vaccination is effective against laboratory confirmed influenza during epidemic seasons. Efforts should be renewed worldwide to further increase uptake of the influenza vaccine in the elderly population. FUNDING: None.
Authors: Kate Russell; Jessie R Chung; Arnold S Monto; Emily T Martin; Edward A Belongia; Huong Q McLean; Manjusha Gaglani; Kempapura Murthy; Richard K Zimmerman; Mary Patricia Nowalk; Michael L Jackson; Lisa A Jackson; Brendan Flannery Journal: Vaccine Date: 2018-02-28 Impact factor: 3.641
Authors: Melissa K Andrew; Vivek Shinde; Lingyun Ye; Todd Hatchette; François Haguinet; Gael Dos Santos; Janet E McElhaney; Ardith Ambrose; Guy Boivin; William Bowie; Ayman Chit; May ElSherif; Karen Green; Scott Halperin; Barbara Ibarguchi; Jennie Johnstone; Kevin Katz; Joanne Langley; Jason Leblanc; Mark Loeb; Donna MacKinnon-Cameron; Anne McCarthy; Allison McGeer; Jeff Powis; David Richardson; Makeda Semret; Grant Stiver; Sylvie Trottier; Louis Valiquette; Duncan Webster; Shelly A McNeil Journal: J Infect Dis Date: 2017-08-15 Impact factor: 5.226
Authors: Michael L Jackson; Jill Ferdinands; Mary Patricia Nowalk; Richard K Zimmerman; Burney Kieke; Manjusha Gaglani; Kempapura Murthy; Joshua G Petrie; Emily T Martin; Jessie R Chung; Brendan Flannery; Lisa A Jackson Journal: BMC Public Health Date: 2021-03-16 Impact factor: 3.295
Authors: Brendan Flannery; Richard K Zimmerman; Larisa V Gubareva; Rebecca J Garten; Jessie R Chung; Mary Patricia Nowalk; Michael L Jackson; Lisa A Jackson; Arnold S Monto; Suzanne E Ohmit; Edward A Belongia; Huong Q McLean; Manjusha Gaglani; Pedro A Piedra; Vasiliy P Mishin; Anton P Chesnokov; Sarah Spencer; Swathi N Thaker; John R Barnes; Angie Foust; Wendy Sessions; Xiyan Xu; Jacqueline Katz; Alicia M Fry Journal: J Infect Dis Date: 2016-05-06 Impact factor: 7.759
Authors: S G Sullivan; K S Carville; M Chilver; J E Fielding; K A Grant; H Kelly; A Levy; N P Stocks; S S Tempone; A K Regan Journal: Epidemiol Infect Date: 2016-04-29 Impact factor: 4.434